Subclinical Inflammation and Prothrombotic State in Heart Transplant Recipients: Impact of Cyclosporin Microemulsion vs. Tacrolimus
Michel White(Montreal Heart Institute), Jacques Genest(McGill University Health Centre), Normand Racine(Montreal Heart Institute), Marie-Hélène Leblanc, Debra Isaac(University of Calgary), Nadia Giannetti(Inserm), Eduardo Ribeiro de Azevêdo(Health Sciences Centre), Haissam Haddad(St. Michael's Hospital), R Ferguson(Astellas Pharma (Japan)), Peter W. Pflugfelder(London Health Sciences Centre), Ross A. Davies(St. Michael's Hospital), Jeffrey R. Burton(Montreal Heart Institute), Heather J. Ross(University of Toronto)
Cited by 25
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
|Nature Genetics|1999|1.7k